BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1902662)

  • 1. Intraocular penetration of topical tissue plasminogen activator.
    Lim JI; Fiscella R; Tessler H; Gagliano DA; Chaques-Alepuz V; Mohler MA
    Arch Ophthalmol; 1991 May; 109(5):714-7. PubMed ID: 1902662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraocular tissue plasminogen activator concentrations after subconjunctival delivery.
    Lim JI; Maguire AM; John G; Mohler MA; Fiscella RG
    Ophthalmology; 1993 Mar; 100(3):373-6. PubMed ID: 8460008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subconjunctival and topical application of recombinant tissue plasminogen activator in rabbits.
    Reggi JR; Hida RY; Hida MM; Nishiwaki-Dantas MC; Suzuki H
    Arq Bras Oftalmol; 2015; 78(1):6-9. PubMed ID: 25714529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of intraocular penetration of topically administered tissue plasminogen activator in dogs.
    Gerding PA; Eurell TE
    Am J Vet Res; 1993 Jun; 54(6):836-9. PubMed ID: 8323049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collagen shield delivery of tissue plasminogen activator: functional and pharmacokinetic studies of anterior segment delivery.
    Murray TG; Jaffe GJ; McKay BS; Han DP; Burke JM; Abrams GW
    Refract Corneal Surg; 1992; 8(1):44-8; discussion 48-53. PubMed ID: 1554639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of immediate postoperative intracameral tissue plasminogen activator (tPA) on anterior chamber fibrin formation in dogs undergoing phacoemulsification.
    Mancuso LA; Nadelstein B; Berdoulay A; Spatola RA
    Vet Ophthalmol; 2019 Jul; 22(4):477-484. PubMed ID: 30773778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal clearance of tissue plasminogen activator in the rabbit.
    Jaffe GJ; Green GD; McKay BS; Hartz A; Williams GA
    Arch Ophthalmol; 1988 Jul; 106(7):969-72. PubMed ID: 3134000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of tissue plasminogen activator in experimental hyphema.
    Lambrou FH; Snyder RW; Williams GA
    Arch Ophthalmol; 1987 Jul; 105(7):995-7. PubMed ID: 3111453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of D-dimer levels in aqueous humor of rabbit eyes with and without induced intraocular fibrin and fibrinolytic treatment.
    Voelter K; Tappeiner C; Riond B; Nuss K; Bruetsch D; Pot SA
    Vet Ophthalmol; 2020 Mar; 23(2):212-218. PubMed ID: 31441205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sonothrombolysis for intraocular fibrin formation in an animal model.
    Yamashita T; Ohtsuka H; Arimura N; Sonoda S; Kato C; Ushimaru K; Hara N; Tachibana K; Sakamoto T
    Ultrasound Med Biol; 2009 Nov; 35(11):1845-53. PubMed ID: 19699025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue plasminogen activator in human aqueous humor and its possible therapeutic significance.
    Tripathi RC; Park JK; Tripathi BJ; Millard CB
    Am J Ophthalmol; 1988 Dec; 106(6):719-22. PubMed ID: 3143267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tissue plasminogen activator on glaucoma filter blebs in rabbits.
    Fourman S; Vaid K
    Ophthalmic Surg; 1989 Sep; 20(9):663-7. PubMed ID: 2510106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue plasminogen activator treatment of postoperative intraocular fibrin.
    Johnson RN; Olsen K; Hernandez E
    Ophthalmology; 1988 May; 95(5):592-6. PubMed ID: 3140157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anticoagulant and fibrinolytic therapies for anterior chamber fibrin following cataract surgery in the rabbit eye].
    Kimura M; Eguchi S; Araie M; Akahoshi T; Kohda F
    Nippon Ganka Gakkai Zasshi; 1992 Oct; 96(10):1240-7. PubMed ID: 1442347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue Plasminogen Activator Effects on Fibrin Volume and the Ocular Proteome in a Juvenile Rabbit Model of Lensectomy.
    Young JB; Buchberger AR; Bogaard JD; Luecke LB; Runquist M; Skumatz CMB; Kassem IS
    Transl Vis Sci Technol; 2021 Dec; 10(14):7. PubMed ID: 34874448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue plasminogen activator in avascular tissues of the eye: a quantitative study of its activity in the cornea, lens, and aqueous and vitreous humors of dog, calf, and monkey.
    Geanon JD; Tripathi BJ; Tripathi RC; Barlow GH
    Exp Eye Res; 1987 Jan; 44(1):55-63. PubMed ID: 3104075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration of cyclosporin A into the rabbit cornea and aqueous humor after topical drop and collagen shield administration.
    Kanpolat A; Batioglu F; Yilmaz M; Akbas F
    CLAO J; 1994 Apr; 20(2):119-22. PubMed ID: 8044977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of fibrinogen, fibrin and fibrin (ogen) degradation products on the tissue plasminogen activator and plasminogen activator inhibitor-1 expressions of vascular endothelial cells in coculture system].
    Cao YJ; Wu YH; Liu CF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jan; 36(1):62-7. PubMed ID: 19099932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracameral tissue plasminogen activator use in a large series of eyes with valved glaucoma drainage implants.
    Zalta AH; Sweeney CP; Zalta AK; Kaufman AH
    Arch Ophthalmol; 2002 Nov; 120(11):1487-93. PubMed ID: 12427061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of postvitrectomy fibrin formation with intraocular tissue plasminogen activator.
    Williams GA; Lambrou FH; Jaffe GA; Snyder RW; Green GD; Devenyi RG; Abrams GW
    Arch Ophthalmol; 1988 Aug; 106(8):1055-8. PubMed ID: 3135790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.